Annual CFF
$239.38 M
+$90.40 M+60.68%
December 31, 2023
Summary
- As of February 7, 2025, IRON annual cash flow from financing activities is $239.38 million, with the most recent change of +$90.40 million (+60.68%) on December 31, 2023.
- During the last 3 years, IRON annual CFF has risen by +$205.13 million (+598.98%).
- IRON annual CFF is now at all-time high.
Performance
IRON Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$426.00 K
-$172.76 M-99.75%
September 30, 2024
Summary
- As of February 7, 2025, IRON quarterly cash flow from financing activities is $426.00 thousand, with the most recent change of -$172.76 million (-99.75%) on September 30, 2024.
- Over the past year, IRON quarterly CFF has dropped by -$34.00 thousand (-7.39%).
- IRON quarterly CFF is now -99.78% below its all-time high of $195.49 million, reached on March 1, 2021.
Performance
IRON Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$197.28 M
-$34.00 K-0.02%
September 30, 2024
Summary
- As of February 7, 2025, IRON TTM cash flow from financing activities is $197.28 million, with the most recent change of -$34.00 thousand (-0.02%) on September 30, 2024.
- Over the past year, IRON TTM CFF has dropped by -$183.16 million (-48.15%).
- IRON TTM CFF is now -48.15% below its all-time high of $380.44 million, reached on September 30, 2023.
Performance
IRON TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IRON Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +60.7% | -7.4% | -48.1% |
| 3 y3 years | +599.0% | -7.4% | -48.1% |
| 5 y5 years | +599.0% | -7.4% | -48.1% |
IRON Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +166.2% | -99.8% | +100.4% | -48.1% | +287.0% |
| 5 y | 5-year | at high | +599.0% | -99.8% | +100.4% | -48.1% | +287.0% |
| alltime | all time | at high | +599.0% | -99.8% | +100.4% | -48.1% | +287.0% |
Disc Medicine Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $426.00 K(-99.8%) | $197.28 M(-0.0%) |
| Jun 2024 | - | $173.19 M(+989.3%) | $197.31 M(+10.9%) |
| Mar 2024 | - | $15.90 M(+104.9%) | $177.97 M(-25.7%) |
| Dec 2023 | $239.38 M(+60.7%) | $7.76 M(+1586.5%) | $239.38 M(-37.1%) |
| Sep 2023 | - | $460.00 K(-99.7%) | $380.44 M(+0.1%) |
| Jun 2023 | - | $153.85 M(+99.0%) | $380.00 M(+68.0%) |
| Mar 2023 | - | $77.31 M(-48.1%) | $226.23 M(+51.9%) |
| Dec 2022 | $148.98 M | $148.81 M(>+9900.0%) | $148.98 M(-245.2%) |
| Sep 2022 | - | $22.00 K(-74.4%) | -$102.57 M(-1.2%) |
| Jun 2022 | - | $86.00 K(+56.4%) | -$103.84 M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $55.00 K(-100.1%) | -$105.51 M(-217.3%) |
| Dec 2021 | $89.93 M(+162.6%) | - | - |
| Dec 2021 | - | -$102.73 M(+8118.4%) | $89.93 M(-53.4%) |
| Sep 2021 | - | -$1.25 M(-20.9%) | $192.80 M(-7.3%) |
| Jun 2021 | - | -$1.58 M(-100.8%) | $208.05 M(-0.8%) |
| Mar 2021 | - | $195.49 M(>+9900.0%) | $209.64 M(+512.1%) |
| Dec 2020 | $34.25 M | $141.00 K(-99.0%) | $34.25 M(+0.4%) |
| Sep 2020 | - | $14.00 M(>+9900.0%) | $34.11 M(+69.7%) |
| Jun 2020 | - | $9000.00(-100.0%) | $20.10 M(+0.0%) |
| Mar 2020 | - | $20.09 M | $20.09 M |
FAQ
- What is Disc Medicine annual cash flow from financing activities?
- What is the all time high annual CFF for Disc Medicine?
- What is Disc Medicine annual CFF year-on-year change?
- What is Disc Medicine quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Disc Medicine?
- What is Disc Medicine quarterly CFF year-on-year change?
- What is Disc Medicine TTM cash flow from financing activities?
- What is the all time high TTM CFF for Disc Medicine?
- What is Disc Medicine TTM CFF year-on-year change?
What is Disc Medicine annual cash flow from financing activities?
The current annual CFF of IRON is $239.38 M
What is the all time high annual CFF for Disc Medicine?
Disc Medicine all-time high annual cash flow from financing activities is $239.38 M
What is Disc Medicine annual CFF year-on-year change?
Over the past year, IRON annual cash flow from financing activities has changed by +$90.40 M (+60.68%)
What is Disc Medicine quarterly cash flow from financing activities?
The current quarterly CFF of IRON is $426.00 K
What is the all time high quarterly CFF for Disc Medicine?
Disc Medicine all-time high quarterly cash flow from financing activities is $195.49 M
What is Disc Medicine quarterly CFF year-on-year change?
Over the past year, IRON quarterly cash flow from financing activities has changed by -$34.00 K (-7.39%)
What is Disc Medicine TTM cash flow from financing activities?
The current TTM CFF of IRON is $197.28 M
What is the all time high TTM CFF for Disc Medicine?
Disc Medicine all-time high TTM cash flow from financing activities is $380.44 M
What is Disc Medicine TTM CFF year-on-year change?
Over the past year, IRON TTM cash flow from financing activities has changed by -$183.16 M (-48.15%)